These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 26112178
1. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis. Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, Cascina A, Meloni F, Perotti C. Respiration; 2015; 90(2):118-28. PubMed ID: 26112178 [Abstract] [Full Text] [Related]
4. Lung transplant recipients on long-term extracorporeal photopheresis. Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C. Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398 [Abstract] [Full Text] [Related]
5. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review. Benden C, Haughton M, Leonard S, Huber LC. J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986 [Abstract] [Full Text] [Related]
6. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction. Gautschi F, Vogelmann T, Ortmanns G, Knörr F, Steinack C, Hage R, Nägeli M, Schuurmans MM. J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041 [Abstract] [Full Text] [Related]
7. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Greer M, Dierich M, De Wall C, Suhling H, Rademacher J, Welte T, Haverich A, Warnecke G, Ivanyi P, Buchholz S, Gottlieb J, Fuehner T. Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373 [Abstract] [Full Text] [Related]
8. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments. Chionis L, Grossman BJ, Hachem R, Commean P, Derfler MC, Vedantham S, Dodds K, Spitznagel E, Atkinson J, Despotis G. Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482 [Abstract] [Full Text] [Related]
9. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation. Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, Aljitawi OS, Lin TL, Singh A, Abhyankar S. J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713 [Abstract] [Full Text] [Related]
10. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS). Sato M, Ohmori-Matsuda K, Saito T, Matsuda Y, Hwang DM, Waddell TK, Singer LG, Keshavjee S. J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813 [Abstract] [Full Text] [Related]
11. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S. J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659 [Abstract] [Full Text] [Related]
13. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR. J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479 [Abstract] [Full Text] [Related]
14. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Benden C, Speich R, Hofbauer GF, Irani S, Eich-Wanger C, Russi EW, Weder W, Boehler A. Transplantation; 2008 Dec 15; 86(11):1625-7. PubMed ID: 19077900 [Abstract] [Full Text] [Related]
15. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation. Pecoraro Y, Carillo C, Diso D, Mantovani S, Cimino G, De Giacomo T, Troiani P, Shafii M, Gherzi L, Amore D, Rendina EA, Venuta F, Anile M. Transplant Proc; 2017 May 15; 49(4):695-698. PubMed ID: 28457374 [Abstract] [Full Text] [Related]
16. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK). Fisher AJ, White M, Goudie N, Kershaw A, Phillipson J, Bardgett M, Lally J, Bevin-Nicholls A, Chadwick T, Bryant A, Russell S, Smith H, Frisby L, Errington R, Carby M, Thompson R, Santhanakrishnan K, Parmar J, Lordan JL, Vale L, Hancock H, Exley C, Gennery AR, Wason JM. BMJ Open Respir Res; 2024 May 09; 11(1):. PubMed ID: 38724453 [Abstract] [Full Text] [Related]
17. Lung transplantation and extracorporeal photopheresis: The answer to bronchiolitis obliterans? Yung GL, Craig V. Transfus Apher Sci; 2015 Apr 09; 52(2):162-6. PubMed ID: 25881738 [Abstract] [Full Text] [Related]
18. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction. EPI Study Group, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G. Transfus Med; 2021 Aug 09; 31(4):292-302. PubMed ID: 33955079 [Abstract] [Full Text] [Related]
19. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience. Vazirani J, Routledge D, Snell GI, Watson D, Paraskeva M, Westall GP, Harrison SJ. Transplant Proc; 2021 Aug 09; 53(1):296-302. PubMed ID: 33039145 [Abstract] [Full Text] [Related]